Publications by authors named "Mario-Demian Mutuleanu"

Claim this Profile
F
Future Directions in Quantitative SPECT-CT Evaluation of Cardiac Transthyretin Amyloidosis: Correlation with Clinical and Morphological Parameters.
Mirela Gherghe, Mario-Demian Mutuleanu, Tatiana Lucia Suta, Liliana Micu, Adina Elena Stanciu

Diagnostics (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation-A Review of the Literature.
Mario-Demian Mutuleanu, Diana Loreta Paun, Alexandra Maria Lazar, Cristina Petroiu, Oana Gabriela Trifanescu

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy-A Single-Tertiary Centre Experience and Review of the Literature.
Alexandra Maria Lazar, Mario-Demian Mutuleanu, Paula Monica Spiridon, Cristian Ioan Bordea, Tatiana Lucia Suta

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging.
Mirela Gherghe, Alexandra Maria Lazar, Maria-Carla Sterea, Paula Monica Spiridon, Natalia Motas, Mario-Demian Mutuleanu

J Cardiovasc Dev Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours.
Mirela Gherghe, Alexandra Maria Lazar, Laurentiu Simion, Ionela-Nicoleta Irimescu, Maria-Carla Sterea, Mario-Demian Mutuleanu

Diagnostics (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT.
Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Maria Lazar

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Cristian Ioan Bordea, Sinziana Ionescu

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The New Radiolabeled Peptide TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
Mirela Gherghe, Alexandra Maria Lazăr, Adina Elena Stanciu, Mario-Demian Mutuleanu, Maria-Carla Sterea

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics Analysis of [F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients' Clinical Management? A Systematic Review from the Literature.
Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Adina Elena Stanciu, Sorina Martin

Diagnostics (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients-The Clinical Significance.
Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Lazar

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis